Literature summary extracted from
Kolesnyk, I.; Struijk, D.G.; Dekker, F.W.; Krediet, R.T.
Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease (2010), Neth. J. Med., 68, 15-23.
Application
EC Number |
Application |
Comment |
Organism |
---|
3.4.15.1 |
medicine |
enzyme inhibitors are useful in treatment of hypertension and heart failure, as well as for peritoneal dialysis patients, because inhibit the local tissue renin-angiotensin system, which results in less development of peritoneal fibrosis and a longer life for the peritoneal membrane, overview |
Homo sapiens |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
3.4.15.1 |
captopril |
the ACE inhibitor shows best renoprotective effect in patients with renal disease |
Homo sapiens |
|
3.4.15.1 |
additional information |
antiproteinuric and renoprotective effects of ACE inhibitors, ACEi, overview |
Homo sapiens |
|
3.4.15.1 |
ramipril |
the ACE inhibitor is associated with a major reduction of proteinuria, slower GFR decline and risk of doubling serum creatinine or progression to end-stage renal disease in patients with nondiabetic kidney disease |
Homo sapiens |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
3.4.15.1 |
Homo sapiens |
- |
- |
- |
Source Tissue
EC Number |
Source Tissue |
Comment |
Organism |
Textmining |
---|
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
3.4.15.1 |
ACE |
- |
Homo sapiens |
3.4.15.1 |
angiotensin-converting enzyme |
- |
Homo sapiens |
General Information
EC Number |
General Information |
Comment |
Organism |
---|
3.4.15.1 |
malfunction |
ACE is involved in risk of GFR decrease, doubling of serum creatinine or progression to ESRD in renal disease |
Homo sapiens |
3.4.15.1 |
physiological function |
enzyme inhibitors are useful in treatment of hypertension and heart failure, as well as for peritoneal dialysis patients, because inhibit the local tissue renin-angiotensin system, which results in less development of peritoneal fibrosis and a longer life for the peritoneal membrane, overview |
Homo sapiens |